Genesis Healthcare, Inc.
GEN
GEN was delisted on the 25th of March, 2021.
68 hedge funds and large institutions have $22.6M invested in Genesis Healthcare, Inc. in 2017 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 23 increasing their positions, 21 reducing their positions, and 13 closing their positions.
10% more repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 21
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
7% less funds holding
Funds holding: 73 → 68 (-5)
33% less capital invested
Capital invested by funds: $33.8M → $22.6M (-$11.2M)
38% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PGCM
Prescott Group Capital Management
Tulsa,
Oklahoma
|
+$2.02M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$571K |
| 3 |
Renaissance Technologies
New York
|
+$310K |
| 4 |
VF
Virtu Financial
New York
|
+$238K |
| 5 |
Millennium Management
New York
|
+$215K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CPA
Columbia Pacific Advisors
Seattle,
Washington
|
-$1.1M |
| 2 |
JP Morgan Chase
New York
|
-$908K |
| 3 |
CA
Cornerstone Advisory
Hunt Valley,
Maryland
|
-$433K |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$157K |
| 5 |
PIA
Phoenix Investment Adviser
New York
|
-$145K |
GEN Hedge Fund Activity: Q4 2017 in Review
68 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Genesis Healthcare, Inc. (GEN) for Q4 2017, worth a combined $22.6M — down 33% from $33.8M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of GEN and 8 opened new positions — a net loss of 5 holders — while 21 trimmed existing stakes and 23 added.
The largest buyer was Prescott Group Capital Management, opening a new position worth an estimated $2.02M. The largest seller was Columbia Pacific Advisors, cutting an estimated $1.1M.
- 68 institutional investors held Genesis Healthcare, Inc. (GEN) as of Q4 2017, down from 73 in Q3 2017.
- Funds reported $22.6M of Genesis Healthcare, Inc. stock for Q4 2017, down 33% quarter-over-quarter.
- 8 funds opened new Genesis Healthcare, Inc. positions in Q4 2017 and 13 closed out, a net change of -5 holders.
- The largest Genesis Healthcare, Inc. buyer in Q4 2017 was Prescott Group Capital Management, an estimated $2.02M added.
- The largest Genesis Healthcare, Inc. seller in Q4 2017 was Columbia Pacific Advisors, an estimated $1.1M sold.
Based on aggregated 13F filings for Q4 2017.